Change language

    Drug Manufacturers - General

    Company Aggregate Score P/E ratio Gross margin EBIT margin ROA Net income per employee
    Amgen Inc.
    52 / 100
    		22 66.1% 24.1% 7.8% €217.07K
    Gilead Sciences, Inc.
    69 / 100
    		17 78.7% 36.1% 13.9% €399.82K
    Kyowa Kirin Co., Ltd.
    50 / 100
    		34 72.6% 17.1% 3.6% €36.84K
    AbbVie Inc.
    53 / 100
    		140 76.2% 21.8% 1.8% €37.77K
    Biogen Inc.
    54 / 100
    		12 73.0% 25.4% 5.5% €183.52K
    Pfizer Inc.
    58 / 100
    		16 73.4% 23.8% 4.7% €105.28K
    Merck & Co., Inc.
    50 / 100
    		11 82.8% 39.4% 14.7% €226.24K
    Roche Holding AG
    48 / 100
    		39 73.5% 28.4% 6.0% €60.17K
    Santen Pharmaceutical Co., Ltd.
    50 / 100
    		19 56.3% 14.0% 7.7% €45.74K
    Sanofi
    53 / 100
    		12 71.6% 26.6% 7.3% €110.11K
    Eli Lilly and Company
    55 / 100
    		41 83.0% 43.9% 16.0% €339.91K
    Chugai Pharmaceutical Co., Ltd.
    51 / 100
    		32 70.4% 45.6% 17.4% €427.75K
    Johnson & Johnson
    53 / 100
    		16 67.9% 24.4% 11.7% €142.38K
    AstraZeneca PLC
    54 / 100
    		0.32 80.3% 21.9% 8.3% €87.09K
    Dechra Pharmaceuticals PLC
    50 / 100
    		-1.6 56.4% 2.2% -1.8% -€13.01K
    Recordati Industria Chimica e Farmaceutica S.p.A.
    51 / 100
    		28 67.8% 25.5% 7.9% €88.92K
    Astellas Pharma Inc.
    52 / 100
    		31 78.4% 5.2% 2.4% €30.06K
    GSK plc
    51 / 100
    		0.11 72.3% 22.4% 9.0% €91.75K
    Virbac SA
    50 / 100
    		20 66.5% 14.3% 7.3% €20.90K
    Bristol-Myers Squibb Company
    51 / 100
    		17 51.0% 16.0% 6.2% €153.66K
    Grifols, S.A.
    51 / 100
    		15 39.5% 18.2% 1.8% €15.26K
    Daiichi Sankyo Company, Limited
    51 / 100
    		23 78.5% 17.3% 8.6% €85.90K
    Novartis AG
    55 / 100
    		20 76.2% 31.1% 13.4% €164.58K

    Notifications